Stenting Renal Arteries Sounds Good In Theory But Evidence Not There – AHRQ
This article was originally published in The Gray Sheet
Executive Summary
Despite the increased use of stents to treat renal artery stenosis, there is little evidence to support revasculari-zation's superiority over medical management, according to a draft review by the Agency for Healthcare Research & Quality
You may also be interested in...
Renal Stenting Coverage Reconsidered: AHRQ Comparative Analysis Effect
CMS' decision last week to reconsider its national coverage policy for renal artery angioplasty and stenting is the agency's first coverage action to grow out of the Effective Health Care Program, the Agency for Healthcare Research & Quality's new comparative effectiveness review arm
Renal Stenting Coverage Reconsidered: AHRQ Comparative Analysis Effect
CMS' decision last week to reconsider its national coverage policy for renal artery angioplasty and stenting is the agency's first coverage action to grow out of the Effective Health Care Program, the Agency for Healthcare Research & Quality's new comparative effectiveness review arm
CORAL Renal Trial To Show Risks, Benefits Of Stenting Over Drugs
The Cardiovascular Outcomes in Renal Atherosclerotic Lesions (CORAL) trial likely will provide the first definitive evidence on the benefits of renal stenting, according to Julio Palmaz, MD, University of Texas